Cargando…
Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy. A total of 245 consecutive patients with de novo HL between 12/2013 and 12/2017 were eval...
Autores principales: | Al-Ibraheem, Akram, Anwer, Farah, Juweid, Malik E., Shagera, Qaid Ahmed, Khalaf, Aysar N., Obeidat, Shahed, Mansour, Areen, Ma’koseh, Mohammad, Halahleh, Khalid, Jaradat, Imad, Almasri, Nidal, Mansour, Asem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587214/ https://www.ncbi.nlm.nih.gov/pubmed/36271128 http://dx.doi.org/10.1038/s41598-022-22032-3 |
Ejemplares similares
-
FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023) -
Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report
por: Ma'koseh, Mohammad, et al.
Publicado: (2023) -
Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP
por: Halahleh, Khalid, et al.
Publicado: (2023) -
Clinical Impact of (18)F-FDG PET/CT on the Management of Gynecologic Cancers: One Center Experience
por: Al-Ibraheem, Akram, et al.
Publicado: (2019) -
The Application of the ThroLy Risk Assessment Model to Predict Venous
Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)